Spots Global Cancer Trial Database for brain neoplasm
Every month we try and update this database with for brain neoplasm cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Measuring Brain Tumor Consistency Using Magnetic Resonance Elastography | NCT05516485 | Brain Neoplasm | Assessment Magnetic Resona... | 18 Years - | University of Southern California | |
| An Open Label Dose Escalation Safety Study of Convection-Enhanced Delivery of IL13-PE38QQR in Patients With Progressive Pediatric Diffuse Infiltrating Brainstem Glioma and Supratentorial High-grade Glioma | NCT00880061 | Brain Neoplasm Glioma | IL13-PE38QQR | - 17 Years | National Institutes of Health Clinical Center (CC) | |
| Tumor Related Epilepsy | NCT02639325 | Epilepsy Cancer Brain Neoplasm | 8 Years - 99 Years | National Institutes of Health Clinical Center (CC) | ||
| A Study for Image-Guided Radiation Therapy in Pediatric Brain Tumors and Side Effects | NCT00187226 | Central Nervous... Brain Tumors | Radiation Thera... Radiation Thera... | 8 Months - 25 Years | St. Jude Children's Research Hospital | |
| Bevacizumab With or Without Surgery for Adult Glioblastomas | NCT01413438 | Glioblastoma Brain Neoplasm | Craniotomy | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| A Study of Motexafin Gadolinium and Temozolomide for the Treatment of Malignant Gliomas | NCT00080054 | Glioma Glioblastoma Astrocytoma Oligodendroglio... Brain Neoplasm | Motexafin Gadol... | 18 Years - | Pharmacyclics LLC. | |
| Subclavian Vein catheterization_Seldinger Vs Modified Seldinger | NCT02090010 | Brain Neoplasm Intracranial An... Cerebrovascular... | Seldinger techn... Modified Seldin... | 20 Years - 80 Years | Seoul National University Hospital | |
| A Trial Comparing Radiosurgery With Surgery for Solitary Brain Metastases | NCT00124761 | Neoplasm Metast... Brain Neoplasm | Surgery + WBRT Radiosurgery + ... | 18 Years - | Royal Adelaide Hospital | |
| A Pilot Study of 1H-Nuclear Magnetic Resonance Spectroscopic Imaging in Pediatric Patients With Primary and Metastatic Brain Tumors | NCT00001574 | Brain Neoplasm Brain Cancer Brain Tumor, Pr... | - 21 Years | National Institutes of Health Clinical Center (CC) | ||
| Bioequivalence Study of Temozolomide in Patients With Primary Tumors of the Central Nervous System | NCT02343081 | Brain Neoplasms... | Temozolomide Temozolomide | 21 Years - | Monte Verde SA | |
| BIRN (Biomedical Informatics Research Network) Resources Facilitate the Personalization of Malignant Brain Tumor | NCT01124461 | GLIOBLASTOMA MU... Brain Neoplasm | 18 Years - 70 Years | Washington University School of Medicine | ||
| Navigated Repetitive Transcranial Magnetic Stimulation in Improving Motor Rehabilitation in Participants With Brain Tumors | NCT03606161 | Brain Neoplasm | Questionnaire A... Transcranial Ma... | - | M.D. Anderson Cancer Center | |
| The PRECISE Trial: Study of IL13-PE38QQR Compared to GLIADEL Wafer in Patients With Recurrent Glioblastoma Multiforme | NCT00076986 | Glioblastoma Mu... | IL13-PE38QQR surgery and cat... prolifespan 20 ... surgery and waf... | 18 Years - | INSYS Therapeutics Inc | |
| Tumor Related Epilepsy | NCT02639325 | Epilepsy Cancer Brain Neoplasm | 8 Years - 99 Years | National Institutes of Health Clinical Center (CC) | ||
| IL13-PE38QQR Infusion After Tumor Resection, Followed by Radiation Therapy With or Without Temozolomide in Patients With Newly Diagnosed Malignant Glioma | NCT00089427 | Glioblastoma Mu... Anaplastic Astr... Oligoastrocytom... | IL13-PE38QQR Surgery for pla... Radiation thera... Temozolomide wi... | 18 Years - | INSYS Therapeutics Inc | |
| Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA | NCT02800486 | Glioblastoma Anaplastic Astr... Anaplastic Olig... Glioma Brain Neoplasm Brain Cancer Brain Tumor Brain Tumor, Re... Brain Neoplasm,... | Intra-arterial ... Intra-arterial ... Hypofractionate... | 18 Years - | Northwell Health | |
| Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors | NCT02754544 | Brain Neoplasm Metastatic Mali... Recurrent Brain... | Direct Electroc... Electrocorticog... | 18 Years - | M.D. Anderson Cancer Center | |
| Evaluation of Factors in Human Brain Tumors | NCT00001171 | Brain Neoplasm Glioblastoma Glioma Pituitary Neopl... | - | National Institutes of Health Clinical Center (CC) | ||
| Clinical Study on 5-aminolevulinic Acid Hydrochloride (5-ALA) for Fluorescence-guided Resection of Malignant Gliomas | NCT02755142 | Brain Neoplasm | Gliolan | 18 Years - 75 Years | medac GmbH | |
| Gene Therapy for the Treatment of Brain Tumors | NCT00001328 | Brain Neoplasm Neoplasm Metast... | Cytovene (Ganci... G1TKSVNa.53 Pro... | 19 Years - | National Institutes of Health Clinical Center (CC) | |
| Laboratory Study of Early Tumor Markers in the Peripheral Blood of Glioblastoma Multiforme Patients | NCT01135875 | Glioblastoma Mu... Healthy Volunte... | GBM Patients Normal Controls | 18 Years - 89 Years | University of Florida | |
| Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors | NCT02754544 | Brain Neoplasm Metastatic Mali... Recurrent Brain... | Direct Electroc... Electrocorticog... | 18 Years - | M.D. Anderson Cancer Center | |
| The PRECISE Trial: Study of IL13-PE38QQR Compared to GLIADEL Wafer in Patients With Recurrent Glioblastoma Multiforme | NCT00076986 | Glioblastoma Mu... | IL13-PE38QQR surgery and cat... prolifespan 20 ... surgery and waf... | 18 Years - | INSYS Therapeutics Inc | |
| Bioequivalence Study of Temozolomide in Patients With Primary Tumors of the Central Nervous System | NCT02343081 | Brain Neoplasms... | Temozolomide Temozolomide | 21 Years - | Monte Verde SA | |
| A Study of GSK2118436 in BRAF Mutant Metastatic Melanoma to the Brain | NCT01266967 | Melanoma and Br... | GSK2118436 | 18 Years - | GlaxoSmithKline | |
| Monteris AutoLITT™ FIM Safety Trial for Recurrent/Progressive Brain Tumors | NCT00747253 | Brain Tumor Brain Tumor, Re... Brain Neoplasm Brain Cancer Glioblastoma Mu... Recurrent Gliob... | AutoLITT system | 18 Years - | Monteris Medical | |
| Seizure Control as a New Metric in Assessing Efficacy of Tumor Treatment in Patients With Low Grade Glioma | NCT04553757 | Brain Neoplasm Low Grade Gliom... Seizure Disorde... | Survey Administ... | - | M.D. Anderson Cancer Center | |
| MRI and Blood Biomarkers for the Prediction of Neurocognitive Decline Following Brain Radiation | NCT05087888 | Brain Neoplasm | Biospecimen Col... Magnetic Resona... Multiparametric... Questionnaire A... | 18 Years - | M.D. Anderson Cancer Center | |
| Surgical Resection of Latent Brain Tumors Prior to Recurrence | NCT04810871 | Brain Neoplasm | Brain Surgery | 18 Years - | Mayo Clinic | |
| Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma | NCT02861898 | Glioblastoma Brain Cancer Brain Neoplasm Brain Tumor Brain Neoplasm,... EGFR Gene Overe... GBM | Intra-arterial ... Intra-arterial ... | 18 Years - | Northwell Health | |
| Seizure Control as a New Metric in Assessing Efficacy of Tumor Treatment in Patients With Low Grade Glioma | NCT04553757 | Brain Neoplasm Low Grade Gliom... Seizure Disorde... | Survey Administ... | - | M.D. Anderson Cancer Center | |
| Gene Therapy for the Treatment of Brain Tumors | NCT00001328 | Brain Neoplasm Neoplasm Metast... | Cytovene (Ganci... G1TKSVNa.53 Pro... | 19 Years - | National Institutes of Health Clinical Center (CC) | |
| Study of the Health Information Needs of Brain Cancer Patients | NCT01130220 | Brain Tumor | Focus Group | 18 Years - 89 Years | University of Florida | |
| Bevacizumab With or Without Surgery for Adult Glioblastomas | NCT01413438 | Glioblastoma Brain Neoplasm | Craniotomy | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| 18F-FET PET in Childhood Brain Tumours | NCT03216148 | Brain Neoplasm | FET-PET | 1 Year - 17 Years | Charite University, Berlin, Germany | |
| Bioequivalence Study of Temozolomide in Patients With Primary Tumors of the Central Nervous System | NCT02343081 | Brain Neoplasms... | Temozolomide Temozolomide | 21 Years - | Monte Verde SA | |
| Brain Neoplasms, Leukemia and Petrochemical Exposures | NCT00042445 | Leukemia Brain Neoplasm | 0 Years - 30 Years | National Institute of Environmental Health Sciences (NIEHS) | ||
| Clinical Study on 5-aminolevulinic Acid Hydrochloride (5-ALA) for Fluorescence-guided Resection of Malignant Gliomas | NCT02755142 | Brain Neoplasm | Gliolan | 18 Years - 75 Years | medac GmbH | |
| Ferumoxytol in Magnetic Resonance Imaging of Pediatric Patients With Brain Tumors | NCT03234309 | Brain Neoplasm | Ferumoxytol Magnetic Resona... | 5 Years - 18 Years | OHSU Knight Cancer Institute | |
| Subclavian Vein catheterization_Seldinger Vs Modified Seldinger | NCT02090010 | Brain Neoplasm Intracranial An... Cerebrovascular... | Seldinger techn... Modified Seldin... | 20 Years - 80 Years | Seoul National University Hospital | |
| Hypertonic Saline 75% vs Mannitol 20% | NCT00199511 | Brain Tumor Tumor, Brain Brain Neoplasm Neoplasm, Supra... Tumor, Supraten... | Administration ... | 18 Years - 75 Years | Lawson Health Research Institute | |
| Navigated Repetitive Transcranial Magnetic Stimulation in Improving Motor Rehabilitation in Participants With Brain Tumors | NCT03606161 | Brain Neoplasm | Questionnaire A... Transcranial Ma... | - | M.D. Anderson Cancer Center | |
| Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA | NCT02800486 | Glioblastoma Anaplastic Astr... Anaplastic Olig... Glioma Brain Neoplasm Brain Cancer Brain Tumor Brain Tumor, Re... Brain Neoplasm,... | Intra-arterial ... Intra-arterial ... Hypofractionate... | 18 Years - | Northwell Health | |
| An Open Label Dose Escalation Safety Study of Convection-Enhanced Delivery of IL13-PE38QQR in Patients With Progressive Pediatric Diffuse Infiltrating Brainstem Glioma and Supratentorial High-grade Glioma | NCT00880061 | Brain Neoplasm Glioma | IL13-PE38QQR | - 17 Years | National Institutes of Health Clinical Center (CC) |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
